Antibody Design and Optimization with Multi-scale Equivariant Graph Diffusion Models for Accurate Complex Antigen Binding

• URL: http://arxiv.org/abs/2506.20957v1
• Date: Thu, 26 Jun 2025 02:45:38 GMT
• Title: Antibody Design and Optimization with Multi-scale Equivariant Graph Diffusion Models for Accurate Complex Antigen Binding
• Authors: Jiameng Chen, Xiantao Cai, Jia Wu, Wenbin Hu,
• Abstract summary: We propose textbfAbMEGD, an end-to-end framework for antibody sequence and structure co-design.<n>AbMEGD combines atomic-level geometric features with residue-level embeddings, capturing local atomic details and global sequence-structure interactions.<n>Experiments using the SAbDab database demonstrate a 10.13% increase in amino acid recovery, 3.32% rise in improvement percentage, and a 0.062AA reduction in root mean square deviation.
• Score: 13.315597171727095
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Antibody design remains a critical challenge in therapeutic and diagnostic development, particularly for complex antigens with diverse binding interfaces. Current computational methods face two main limitations: (1) capturing geometric features while preserving symmetries, and (2) generalizing novel antigen interfaces. Despite recent advancements, these methods often fail to accurately capture molecular interactions and maintain structural integrity. To address these challenges, we propose \textbf{AbMEGD}, an end-to-end framework integrating \textbf{M}ulti-scale \textbf{E}quivariant \textbf{G}raph \textbf{D}iffusion for antibody sequence and structure co-design. Leveraging advanced geometric deep learning, AbMEGD combines atomic-level geometric features with residue-level embeddings, capturing local atomic details and global sequence-structure interactions. Its E(3)-equivariant diffusion method ensures geometric precision, computational efficiency, and robust generalizability for complex antigens. Furthermore, experiments using the SAbDab database demonstrate a 10.13\% increase in amino acid recovery, 3.32\% rise in improvement percentage, and a 0.062~\AA\ reduction in root mean square deviation within the critical CDR-H3 region compared to DiffAb, a leading antibody design model. These results highlight AbMEGD's ability to balance structural integrity with improved functionality, establishing a new benchmark for sequence-structure co-design and affinity optimization. The code is available at: https://github.com/Patrick221215/AbMEGD.

Related papers

• DISPROTBENCH: A Disorder-Aware, Task-Rich Benchmark for Evaluating Protein Structure Prediction in Realistic Biological Contexts [76.59606029593085]
  DisProtBench is a benchmark for evaluating protein structure prediction models (PSPMs) under structural disorder and complex biological conditions.<n>DisProtBench spans three key axes: data complexity, task diversity, and Interpretability.<n>Results reveal significant variability in model robustness under disorder, with low-confidence regions linked to functional prediction failures.
  arXiv  Detail & Related papers  (2025-06-18T23:58:22Z)
• Towards More Accurate Full-Atom Antibody Co-Design [44.06939390661133]
  Co-design represents a critical frontier in drug development, where accurate prediction of structure of complementarity-determining regions is essential for targeting specific equivariants.<n>Despite recent advances in graph neural networks for antibody design, current approaches often fall short in capturing the intricate interactions that govern antibody-antigen recognition and binding specificity.<n>We present Igformer, a novel end-to-end framework that addresses these limitations through personalized antibody-antigen binding interfaces.
  arXiv  Detail & Related papers  (2025-02-11T13:33:28Z)
• Relation-Aware Equivariant Graph Networks for Epitope-Unknown Antibody Design and Specificity Optimization [61.06622479173572]
  We propose a novel Relation-Aware Design (RAAD) framework, which models antigen-antibody interactions for co-designing sequences and structures of antigen-specific CDRs.<n> Furthermore, we propose a new evaluation metric to better measure antibody specificity and develop a contrasting specificity-enhancing constraint to optimize the specificity of antibodies.
  arXiv  Detail & Related papers  (2024-12-14T03:00:44Z)
• A Hierarchical Training Paradigm for Antibody Structure-sequence Co-design [54.30457372514873]
  We propose a hierarchical training paradigm (HTP) for the antibody sequence-structure co-design. HTP consists of four levels of training stages, each corresponding to a specific protein modality. Empirical experiments show that HTP sets the new state-of-the-art performance in the co-design problem.
  arXiv  Detail & Related papers  (2023-10-30T02:39:15Z)
• Cross-Gate MLP with Protein Complex Invariant Embedding is A One-Shot Antibody Designer [58.97153056120193]
  The specificity of an antibody is determined by its complementarity-determining regions (CDRs) Previous studies have utilized complex techniques to generate CDRs, but they suffer from inadequate geometric modeling. We propose a textitsimple yet effective model that can co-design 1D sequences and 3D structures of CDRs in a one-shot manner.
  arXiv  Detail & Related papers  (2023-04-21T13:24:26Z)
• End-to-End Full-Atom Antibody Design [28.199522831859998]
  There are two major defects in current learning-based methods, making them suboptimal or resource-intensive. We propose dynamic Multi-channel Equivariant grAph Network (dyMEAN), an end-to-end full-atom model for E(3) antibody design. Both 1D sequences and 3D structures are updated via an adaptive multi-channel encoder that is able to process protein residues of variable sizes when considering full atoms. Experiments on CDR-H3 design, complex structure prediction, and affinity optimization demonstrate the superiority of our end-to-end framework and full-atom modeling.
  arXiv  Detail & Related papers  (2023-02-01T03:13:19Z)
• xTrimoABFold: De novo Antibody Structure Prediction without MSA [77.47606749555686]
  We develop a novel model named xTrimoABFold to predict antibody structure from antibody sequence. The model was trained end-to-end on the antibody structures in PDB by minimizing the ensemble loss of domain-specific focal loss on CDR and the frame-aligned point loss.
  arXiv  Detail & Related papers  (2022-11-30T09:26:08Z)
• Conditional Antibody Design as 3D Equivariant Graph Translation [28.199522831859998]
  We propose Multi-channel Equivariant Attention Network (MEAN) to co-design 1D sequences and 3D structures of CDRs. Our method significantly surpasses state-of-the-art models in sequence and structure modeling, antigen-binding CDR design, and binding affinity optimization.
  arXiv  Detail & Related papers  (2022-08-12T01:00:59Z)
• Iterative Refinement Graph Neural Network for Antibody Sequence-Structure Co-design [35.215029426177004]
  We propose a generative model to automatically design antibodies with enhanced binding specificity or neutralization capabilities. Our method achieves superior log-likelihood on the test set and outperforms previous baselines in designing antibodies capable of neutralizing the SARS-CoV-2 virus.
  arXiv  Detail & Related papers  (2021-10-09T18:23:32Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.